About the Authors
- Karen Louise Thomsen
-
Affiliation Liver Failure Group, UCL Institute for Liver and Digestive Health, University College London Medical School, London, United Kingdom
- Jane Macnaughtan
-
Affiliation Liver Failure Group, UCL Institute for Liver and Digestive Health, University College London Medical School, London, United Kingdom
- Giovanni Tritto
-
Affiliation Liver Failure Group, UCL Institute for Liver and Digestive Health, University College London Medical School, London, United Kingdom
- Rajeshwar P. Mookerjee
-
Affiliation Liver Failure Group, UCL Institute for Liver and Digestive Health, University College London Medical School, London, United Kingdom
- Rajiv Jalan
-
* E-mail: r.jalan@ucl.ac.uk
Affiliation Liver Failure Group, UCL Institute for Liver and Digestive Health, University College London Medical School, London, United Kingdom
Competing Interests
Rajiv Jalan received research funding from Vital Therapies, has served on Scientific Advisory Board for Conatus Pharma, and received lecture fees from Gambro and has on-going research collaboration with Gambro, Grifols and is the Principal Investigator of an Industry sponsored study (Sequana Medical). He is also inventor for a drug, L-ornithine phenyl acetate which UCL has licensed to Ocera Therapeutics. He is also the founder of UCL spin-out company Yaqrit ltd. and Cyberliver ltd. All other authors have nothing to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RJ. Performed the experiments: JM GT. Analyzed the data: KLT RJ. Contributed reagents/materials/analysis tools: JM GT. Wrote the paper: KLT RJ RM.